Healthcare Mar 01, 2022 02:24 PM (GMT+8) · EqualOcean
Suzhou Ruibo Biotechnology Co., Ltd. recently announced that Dr. Gan liming, former vice president of global R & D of AstraZeneca and head of AstraZeneca cvrm R & D center, officially joined Ruibo biology as president of global R & D and chief medical officer (CMO). Gan Liming will be mainly responsible for the company's pipeline layout, product development strategy customization Important work such as R & D promotion and registration of pipeline varieties, and served as the CEO of Ruibo biology's first overseas (Sweden) R & D center.